CD274 and melanoma: To explore whether TCRγδ-T can also eliminate PD-L1-expressing tumor cells in other cancer types, we tested the efficacy of CAR-, δ-TCRγδ-T or γ-TCRγδ-T cells in the SK-MEL-5 melanoma xenograft model.